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Growing Up in Singapore Towards healthy Outcomes (GUSTO) is Singapore’s largest birth cohort study to date. The main aim of 
GUSTO is to evaluate the role of developmental factors in the early pathways to metabolic compromise. Detailed data is collected for 
a range of environmental exposures in the parents and offspring, and allergic disorders are among a number of outcomes assessed 
in infancy and childhood. Under the Allergy domain of GUSTO, this integrated study will describe the epidemiology of allergic 
manifestations and different phenotypes in the Asian context and help shed light on the association of metabolic disease to allergy. 
Epigenetic mechanisms and associations with other childhood disorders will also be explored. The aim of this report is to focus on 
methodology of GUSTO, and to suggest similar approaches (i.e., integrated cohort studies on pediatric allergy) worldwide. Recruitment 
commenced in 2009 with a cohort of 1,163 pregnant mothers in their first trimester. The mothers and children were followed 
throughout pregnancy and follow-up will continue until the child reaches 3 years of age. Preliminary results showed that 39.8% of the 
mothers had a personal history of having at least one allergic disease, which included asthma, eczema and allergic rhinitis. Further data 
collection and analyses are still ongoing. Allergy is a complex spectrum of disorders with numerous poorly-understood aspects. The 
ongoing GUSTO cohort study, with its longitudinal design and multi-disciplinary nature, may provide new insights into developmental 
influences on allergy. As a Singapore-based study, it will be the first integrated allergy cohort in Southeast Asia, of which recruitment 
started during pregnancy.
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INTRODUCTION
Allergic diseases such as asthma, rhinitis, and atopic eczema are 
considered the most common group of diseases in children and 
are an important cause of somatic and psychosocial morbidity, 
affecting quality of life of patients and their families [1]. Moreover, 
a lot of aspects of allergic diseases are still unknown. As a result 
there is a need to better understand the pathogenesis, natural 
course, prevention and treatment of allergic disease. 
It is now generally accepted that allergic disorders result 
from the complex interplay between genetic factors and the 
environment. However, the exact reasons for the increase of 
allergic diseases during the last three decades are still largely 
unknown, and the Hygiene Hypothesis only explains part of the 
increase [2]. Other environmental and lifestyle factors have been 
implicated but the exact underlying mechanisms and triggers 
remain speculative [3]. In addition, it still needs to be elucidated 
whether there are any exposures that have causal roles in the 
similar increases in allergic and metabolic diseases such as 
diabetes [4, 5] and obesity [6] over recent decades. The Growing 
Up in Singapore Towards healthy Outcomes (GUSTO) cohort study 
is well placed to explore this hypothesis. Additionally, the GUSTO 
study will examine a number of other unanswered questions 
about different aspects of allergy. These include: the role of 
epigenetic mechanisms in the pathogenesis of allergic diseases, 
the underlying mechanisms of heterogeneous presentations of 
allergy within families, even among identical twins [7], and the 
mechanisms behind the dynamics of allergic symptoms in young 
children [8] and the growing-out of an allergy.
Singapore is a modern Southeast Asian city state with a 
westernised population. The disease profile of the nation is 
dominated by ailments such as cancer, metabolic syndrome and 
allergy. A local cross-sectional study in the year 2001 showed that 
27.4% of 12 to 15 year-olds had been medically diagnosed with 
asthma [9]. Another study found that atopic dermatitis affected 
20.8% of Singaporean school children [10]. In fact, symptoms 
related to allergy were found to be already prevalent at a younger 
age, with a significant 42.2% of a cohort having had chronic itchy 
skin, wheeze or rhino-conjunctivitis by 24 months of life [11]. The 
high prevalence of allergy comes with an economic burden, with 
the total healthcare cost of asthma alone in Singapore estimated 
to be US$33.93 million per annum [12].
 
Aim
Because of the complexity of allergy and because of its 
possible association with other pathologies, it was decided to 
set up an innovative Singaporean cohort (as part of GUSTO – see 
below) to study different aspects of allergic diseases, such as its 
epidemiology and clinical presentations, with a focus on different 
phenotypes of allergic manifestations. Within the study we aim to 
analyse the association of metabolic diseases to allergy. 
In addition, disease mechanisms, including epigenetic 
mechanisms and associations with other childhood diseases 
and features will be explored. GUSTO is the first birth cohort in 
Southeast Asia that aims to study multiple types of allergy. This is 
significant as Asia is the most populous continent, and an increase 
in the prevalence of allergy will result in tremendous burden [13]. 
The aim of this report is to focus on methodology of GUSTO, being 
an innovative approach to research in pediatric allergy. 
Methodology
An introduction to GUSTO
GUSTO is Singapore’s largest and most comprehensive birth 
cohort study to date [14]. With recruitment commencing in 2009, it 
is a currently ongoing cohort study of pregnant women and their 
offspring, with recruitment beginning in the first trimester. The last 
GUSTO baby was born in May 2011. Mothers have been followed 
throughout pregnancy and their offspring will be seen until the 
child reaches 3 years of age. It is currently in plan to set up a longer 
follow-up through childhood and into adulthood.
The primary objective of the GUSTO birth cohort study is to 
evaluate the role of developmental factors in the early pathways 
to metabolic compromise, namely obesity and type 2 diabetes 
mellitus. 
With the intention of being a holistic cohort study not limited to 
a single field, GUSTO is further subdivided into several secondary 
domains with individual objectives to maximise the research 
opportunities that have arisen (Fig. 1). Such a domain is Allergy—
the concern of this article. Researchers will lead work in their 
respective domains, in addition to the possibility of co-operating 
with other domains in a multi-disciplinary approach.
Design of the GUSTO allergy studies
All pregnant mothers (and their offspring) enrolled in the main 
GUSTO study were eligible for recruitment into the allergy domain. 
To qualify for GUSTO, mothers had to be Singapore citizens or apallergy.org
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permanent residents aged 18 years and above who are Chinese, 
Malay or Indian with homogenous parental ethnic background 
and have the intention to eventually deliver in the 2 major public 
maternity units (National University Hospital and KK Women’s 
and Children’s Hospital) and to reside in Singapore for the next 
5 years. Only healthy women were recruited and thus mothers 
on chemotherapy, psychotropic drugs or with type 1 diabetes 
mellitus were excluded. In addition, only women who agreed to 
donate birth tissues (i.e., cord blood, cord and placenta) at delivery 
were included. These tissues would then be utilized to study the 
epigenetic processes associated with the development of allergy.
Women who were recruited in the first trimester before 14 
weeks returned to the hospital for 4 follow-up visits. Detailed 
interviews were conducted in the clinic during the recruitment 
visit and at 26-28 weeks gestation. Information gathered during 
interviews included demographics, social data, lifestyle, diet, 
medications, personal health and family history of disease 
(including allergy). 
Upon delivery, birth tissues were obtained and anthropometric 
measurements of the newborn were made. During infancy, the 
babies are examined at home at 3 weeks, 3 month and every 3 
months thereafter till 15 months of age. The toddler will be then 
seen at the study clinic site at 18 months, 24 months and 36 
months. 
A personal history of allergy was taken from the mother in 
the 3rd week post-delivery. Information gathered during the 
abovementioned visits included but was not limited to the 
child’s diet, medications (and supplements), immunisations and 
environment. The child will be also screened for the onset of 
symptoms in addition to other illnesses, and biological samples 
(e.g., breast-milk, stool and nasal swabs) will be also taken at 
designated visits. Signs indicative of allergy will be recorded in a 
way that was not temporally restricted to scheduled follow-ups. 
For example, in the assessment of eczema, photographs of the 
rash are taken by the mother and sent to pediatric allergists for 
verification. 
Throughout the study, case definitions of atopic eczema, rhinitis, 
and asthma, adapted and validated for young children from The 
International Study of Asthma and Allergy in Children definitions 
[15], were standardized in the questionnaires to ensure consistency 
during the interviews and house visits. Symptomatology of the 
conditions was assessed thoroughly. Photos of skin conditions 
like hives and urticaria were attached to help parents identify and 
report these conditions.
An extensive assessment of the toddler is planned at age 18 
months. This will include a detailed history-taking, a clinical 
examination of the skin, upper and lower respiratory tract systems 
and allergy testing. Proposed investigations at this age include 
standard skin prick testing for common allergens. Longer term 
follow-up through childhood is also planned which would include 
repeat skin prick assessment and lung function test.
Implementation of the GUSTO allergy studies
Enrolment of mothers started in June 2009 up till September 
2010, with a total of 1,163 recruited mothers out of the 3,335 
assessed for eligibility (1,880 were eligible). The study protocol was 
approved by the Institutional Review Board and all participants 
gave their written, informed consent. Questionnaires were 
administered and samples were taken by trained personnel to 
ensure validity of information collected. All mothers have since 
delivered by May 2011. 
The investigators of the GUSTO allergy study are pediatric 
allergists from the National University Hospital and KK Women’s 
and Children’s Hospital, working in collaboration with colleagues 
and specialists from other departments. 
Preliminary findings
Recruitment for the study was completed in September 2010 
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Fig. 1. The main and surrounding secondary domains of Growing Up in 
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with 1,163 pregnant women recruited into the main GUSTO cohort 
(current drop-out rate = 12.1%). All of the women have delivered 
but data collection and analyses are still ongoing. Amongst the 
participants recruited, 56% were Chinese, 26% Malay and 18% 
Indian. The women were on average 30 years of age (range, 18-
46 years). At least 55% of them had completed pre-university 
education and 70% were in paid employment at the time of 
recruitment. Results showed that 39.8% of the mothers had a 
personal history of having at least one allergic disease, which 
included asthma, ec zema and allergic rhinitis. 
Of the babies delivered, at least 945 have reached 3 months of 
age by end-May 2011 and preliminary data showed that 10.4% 
have had symptoms suggestive of chronic rhinitis (defined as 
running nose, blocked or congested nose, snoring or noisy 
breathing during sleep or when awake that has lasted for 2 or 
more weeks duration), 10.3% have had a possible eczematous rash 
with 3.6% already diagnosed with atopic eczema, and 5.6% have 
had wheezing episodes. Further analyses are ongoing. 
DISCUSSION
There have been numerous cohort studies carried out on 
various aspects of allergy. Birth cohorts such as those in Australia 
[16], the USA [17] and cohorts that comprise the GA
2LEN project in 
Europe [18] have identified numerous potential risk factors for the 
development of allergic diseases. These include gene associations 
and a variety of environmental factors in early life. 
The advantage of the longitudinal nature birth cohorts is the 
ability to detect cause-effect relationships. Besides sharing this 
advantage with previous cohorts, GUSTO also includes new and 
exciting opportunities in the study of pediatric allergy due to its 
unique nature, as elaborated below.
Firstly, GUSTO is a cohort study with multiple domains, with 
a primary aim of evaluating early factors leading to metabolic 
compromise. The multi-domain nature of GUSTO allows 
researchers to utilise findings from and draw on the expertise 
of other GUSTO domains through collaborations with other 
specialists. This creates the prospect of exploring a wider variety of 
associations and also in greater depth, which is needed to unlock 
the multi-factorial nature of allergic disease.
Secondly, GUSTO aims to explore the role of epigenetics in 
allergy, through conducting studies on different tissues. There is 
increasing evidence pointing to the influence of prenatal and early 
life exposures on the development of allergic disease, in particular 
that transient environmental pressures can have permanent 
effects on gene regulation and expression through epigenetic 
mechanisms [19]. The GUSTO design offers the opportunity to 
examine (in relation to clinical outcomes) the epigenetic effects 
of maternal diet, in addition to epigenetic markers at birth as a 
function of fetal growth and subsequently over development and 
its effect on allergy. 
The GUSTO allergy domain, like other birth cohorts of allergy, 
uses standard case definitions of asthma, rhinitis and eczema to 
ascertain the presence of allergy in subjects. Interviewers were 
well versed in clinical symptoms and signs in assessing for allergy. 
Standard skin prick tests will also help in identifying specific 
allergens prevalent in Singapore such as house dust mites [20]. 
This will help shed light on mechanisms underlying different types 
of allergy.
There is a need to obtain local epidemiological data on allergy in 
Singaporeans and to detail the natural history of the local disease 
phenotype. A unique feature of GUSTO is that the three distinct 
ethnic groups, Chinese, Malays and Indians, in the Singaporean 
population allows us to examine the extent to which genomic 
variation influences allergic phenotype. Singapore’s advanced 
infrastructure provides advantages for population-based research 
studies. Every citizen has a unique identity card number which 
promises the potential for linkages using national databases. In 
addition, being a small country, there is ease of subject follow-up.
A large number of specific sub-studies on pediatric allergy 
are now planned in GUSTO; some of them have started, and 
preliminary data are now gathered. These include studies on 
the role of vitamin D in allergic sensitization, house dust mite 
sensitisation through life, the role of bacterial colonisation in the 
development of eczema, epigenetic mechanisms of expression 
of allergy genes at birth, and its association with prenatal 
environmental conditions (diet, allergen exposure, and smoking), 
early studies of filaggrin, and phenotypes of rhinitis during the first 
year of life and the role of respiratory viruses.
In conclusion, allergy is a complex spectrum of diseases with 
numerous unexplored aspects. The GUSTO allergy study is a major 
birth cohort study with an innovative design and multi-disciplinary 
nature. It has the potential to shed light on the unanswered 
questions in allergy. As a Singapore-based study, it will be the first 
major Southeast Asian cohort on allergy to be conducted.apallergy.org
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